A Study to Compare Vincristine to Sirolimus for Treatment of High Risk Vascular Tumors

Clinical trial NCT02110069 · TERMINATED

Trial details

NCT number: NCT02110069
Sponsor: Boston Children's Hospital
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Kaposiform Hemangioendothelioma (KHE)Kasabach-Merritt Syndrome Tufted Angioma

Start date: 2017-06-14
Primary completion: 2019-10-02
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.